Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page footer, signaling an updated version of the page content.
    Difference
    0.1%
    Check dated 2026-07-05T12:26:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a new build of the page. The change does not alter study data, eligibility criteria, or trial details.
    Difference
    0.1%
    Check dated 2026-06-28T09:12:43.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions label has been updated to Intervention/Treatment, with Revision updated to v3.6.0. The notice No longer looking for participants confirms that the study is not currently recruiting.
    Difference
    0.4%
    Check dated 2026-06-14T03:42:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, updating the revision label from v3.5.4 to v3.5.5. This is a minor metadata update and does not modify the study information or layout.
    Difference
    0.1%
    Check dated 2026-06-06T23:24:13.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-05-16T09:45:53.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-clinical site/software update.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:50.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.